BDNF as a Mediator of Antidepressant Response: Recent Advances and Lifestyle Interactions
Open accessThe DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Abstract
Conventional antidepressants are widely employed in several psychiatric and neurologic disorders, yet the mechanisms underlying their delayed and partial therapeutic effects are only gradually being understood. This narrative review provides an up-to-date overview of the interplay between antidepressant treatment and Brain-Derived Neurotrophic Factor (BDNF) signaling. In addition, the impact of nutritional, environmental and physiological factors on BDNF and the antidepressant response is outlined. This review underlines the necessity to include information on lifestyle choices in testing and developing antidepressant treatments in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), have been shown to increase BDNF levels both in peripheral blood and in specific brain regions such as the hippocampus, which is critical for mood regulation and neurogenesis [3,41].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conventional antidepressants, particularly SSRIs and SNRIs, are known to increase BDNF levels over time, which correlates with their delayed therapeutic effect [3,41].”
From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [41]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–214 of 214
Poggini, S., Bon, G. M., Golia, M. T., Albanese, N. C., Viglione, A., Poleggi, A., Limatola, C., Maggi, L., & Branchi, I. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113256 · Cited by 21
Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: An open-label pilot trial
Smith, D. J., Sarris, J. J., Dowling, N. L., O’Connor, M., & Ng, C. H. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1283128 · Cited by 20
Alboni, S., van Dijk, R. M., Poggini, S., Milior, G., Perrotta, M., Drenth, T., Brunello, N., Wolfer, D. P., Limatola, C., Amrein, I., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.191 · Cited by 19
McNamara, R. K., Able, J. A., Liu, Y., Jandacek, R. J., Rider, T., Tso, P., & Lipton, J. W. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.09.010 · Cited by 18
Deyama, S., & Kaneda, K. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112844 · Cited by 18
The effect of enriched environment across ages: A study of anhedonia and BDNF gene induction
Dong, B. E., Xue, Y., & Sakata, K. (2018) · Genes Brain & Behavior · doi:10.1111/gbb.12485 · Cited by 17
Early-Life Stress Reprograms Stress-Coping Abilities in Male and Female Juvenile Rats
Pallarés, M. E., Monteleone, M. C., Pastor, V. E., Balboa, J. G., Alzamendi, A., Brocco, M. A., & Antonelli, M. C. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02527-2 · Cited by 16
Early response as predictor of final remission in elderly depressed patients
Kok, R., van Baarsen, C., Nolen, W. A., & Heeren, T. J. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2261 · Cited by 15
Nasca, C., Barnhill, O., DeAngelis, P., Watson, K. T., Lin, J., Beasley, J., Young, S. P., Myoraku, A., Dobbin, J., Bigio, B., et al. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100407 · Cited by 14
Arnold, O., Saletu, B., Anderer, P., Assandri, A., Padova, C. D., Corrado, M. E., & Saletu-Zyhlarz, G. M. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.01.004 · Cited by 12
Tomita, T., Yasui‐Furukori, N., Nakagami, T., Kaneda, A., & Kaneko, S. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.11.012 · Cited by 11
Xing, Y., Sun, T., Li, G., Xu, G., Cheng, J. R., & Gao, S. (2021) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23993 · Cited by 10
Ielmini, M., Caselli, I., Ceccon, F., Diurni, M., Poloni, N., & Callegari, C. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4416 · Cited by 4
Faron‐Górecka, A., Kuśmider, M., Gruca, P., Pabian, P., Korlatowicz, A., Solich, J., Kolasa, M., & Dziedzicka‐Wasylewska, M. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147948 · Cited by 3
Cited by
From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine
Toader, C., Șerban, M., Munteanu, O., Covache-Busuioc, R.-A., Enyedi, M., Ciurea, A. V., & Tătaru, C. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094271 · Cited by 184
Cavaleri, D., Moretti, F., Bartoccetti, A., Mauro, S., Crocamo, C., Carrà, G., & Bartoli, F. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105159 · Cited by 146
Treatment-resistant depression: molecular mechanisms and management
Kajumba, M. M., Kakooza‐Mwesige, A., Nakasujja, N., Attix, D. K., & Canli, T. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00205-y · Cited by 104
Șerban, M., Toader, C., & Covache-Busuioc, R.-A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157498 · Cited by 73
Lei, M., Liu, Q., Nie, J., Huang, R., Mei, Y., Pan, D., Chen, Y., & Liu, W. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70138 · Cited by 70
Metadata
- Authors
- Cubillos, S., Engmann, O., & Brancato, A.
- Affiliations
- Friedrich Schiller University Jena (DE)
- University of Palermo (IT)
- Corresponding author
- Engmann, Olivia
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-11-21
- Volume
- 23
- Issue
- 22
- Pages
- 14445
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9698349
- OpenAlex
- W4309787614
- Cited by
- 47
- References
- 214
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 13 · 2023: 12
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS UniPA (University of Palermo) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Common Library Network (Der Gemeinsame Bibliotheksverbund) (submittedVersion, cc-by)
- Funders
- Carl-Zeiss-Foundation (#P2019-01-0006, 737/2021, FFR 2019/2022)
- European Union—NextGenerationEU (#P2019-01-0006, 737/2021, FFR 2019/2022)
- University of Palermo (#P2019-01-0006, 737/2021, FFR 2019/2022)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- brain-derived neurotrophic factor, antidepressant response, antidepressant mechanism, BDNF signaling, lifestyle factors, nutrition, environmental factors, physiological factors, antidepressant drug development
- MeSH terms
- Antidepressive Agents, Signal Transduction, Brain-Derived Neurotrophic Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.